COPD management: need for more consensus - Authors' reply

Lancet Respir Med. 2015 Jul;3(7):e22-3. doi: 10.1016/S2213-2600(15)00179-4.

Authors

Christopher B Cooper¹, Igor Barjaktarevic²

Affiliations

¹ Departments of Medicine, David Geffen School of Medicine, University of California, Los Angeles, CA 90095, USA; Physiology, David Geffen School of Medicine, University of California, Los Angeles, CA 90095, USA. Electronic address: [email protected].
² Departments of Medicine, David Geffen School of Medicine, University of California, Los Angeles, CA 90095, USA.

PMID: 26170080
DOI: 10.1016/S2213-2600(15)00179-4

No abstract available

Publication types

Letter
Comment

MeSH terms

Adrenergic beta-Agonists / therapeutic use*
Algorithms*
Humans
Muscarinic Antagonists / therapeutic use*
Oxygen Inhalation Therapy*
Pneumonectomy*
Pulmonary Disease, Chronic Obstructive / therapy*
Respiratory Therapy*

Substances

Adrenergic beta-Agonists
Muscarinic Antagonists